Literature DB >> 24211590

Cold stress accentuates pressure overload-induced cardiac hypertrophy and contractile dysfunction: role of TRPV1/AMPK-mediated autophagy.

Songhe Lu1, Dezhong Xu.   

Abstract

Severe cold exposure and pressure overload are both known to prompt oxidative stress and pathological alterations in the heart although the interplay between the two remains elusive. Transient receptor potential vanilloid 1 (TRPV1) is a nonselective cation channel activated in response to a variety of exogenous and endogenous physical and chemical stimuli including heat and capsaicin. The aim of this study was to examine the impact of cold exposure on pressure overload-induced cardiac pathological changes and the mechanism involved. Adult male C57 mice were subjected to abdominal aortic constriction (AAC) prior to exposure to cold temperature (4 °C) for 4 weeks. Cardiac geometry and function, levels of TRPV1, mitochondrial, and autophagy-associated proteins including AMPK, mTOR, LC3B, and P62 were evaluated. Sustained cold stress triggered cardiac hypertrophy, compromised depressed myocardial contractile capacity including lessened fractional shortening, peak shortening, and maximal velocity of shortening/relengthening, enhanced ROS production, and mitochondrial injury, the effects of which were negated by the TRPV1 antagonist SB366791. Western blot analysis revealed upregulated TRPV1 level and AMPK phosphorylation, enhanced ratio of LC3II/LC3I, and downregulated P62 following cold exposure. Cold exposure significantly augmented AAC-induced changes in TRPV1, phosphorylation of AMPK, LC3 isoform switch, and p62, the effects of which were negated by SB366791. In summary, these data suggest that cold exposure accentuates pressure overload-induced cardiac hypertrophy and contractile defect possibly through a TRPV1 and autophagy-dependent mechanism.
Copyright © 2013. Published by Elsevier Inc.

Entities:  

Keywords:  Autophagy; Cold exposure; Heart failure; Mitochondrial; Pressure overload

Mesh:

Substances:

Year:  2013        PMID: 24211590     DOI: 10.1016/j.bbrc.2013.10.128

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  12 in total

Review 1.  Ion channels in the regulation of autophagy.

Authors:  Artem Kondratskyi; Kateryna Kondratska; Roman Skryma; Daniel J Klionsky; Natalia Prevarskaya
Journal:  Autophagy       Date:  2017-11-23       Impact factor: 16.016

Review 2.  The role of autophagy in cardiac hypertrophy.

Authors:  Lanfang Li; Jin Xu; Lu He; Lijun Peng; Qiaoqing Zhong; Linxi Chen; Zhisheng Jiang
Journal:  Acta Biochim Biophys Sin (Shanghai)       Date:  2016-04-15       Impact factor: 3.848

Review 3.  Warming Up to New Possibilities with the Capsaicin Receptor TRPV1: mTOR, AMPK, and Erythropoietin.

Authors:  Kenneth Maiese
Journal:  Curr Neurovasc Res       Date:  2017       Impact factor: 1.990

Review 4.  Physiological and Pathological Role of TRPV1, TRPV2 and TRPV4 Channels in Heart.

Authors:  Alexandr S Gorbunov; Leonid N Maslov; Amteshwar S Jaggi; Nirmal Singh; Luciano De Petrocellis; Alla A Boshchenko; Ali Roohbakhsh; Vladimir V Bezuglov; Peter R Oeltgen
Journal:  Curr Cardiol Rev       Date:  2019

Review 5.  Emerging regulation and function of betatrophin.

Authors:  Yi-Hsin Tseng; Yung-Hsin Yeh; Wei-Jan Chen; Kwang-Huei Lin
Journal:  Int J Mol Sci       Date:  2014-12-18       Impact factor: 5.923

6.  Cryopreservation of Primary Mouse Neurons: The Benefit of Neurostore Cryoprotective Medium.

Authors:  Francesca Pischedda; Caterina Montani; Julia Obergasteiger; Giulia Frapporti; Corrado Corti; Marcelo Rosato Siri; Mattia Volta; Giovanni Piccoli
Journal:  Front Cell Neurosci       Date:  2018-03-22       Impact factor: 5.505

7.  Stress injuries and autophagy in mouse hippocampus after chronic cold exposure.

Authors:  Ting-Ting Qu; Jie-Xin Deng; Rui-Ling Li; Zhan-Jun Cui; Xiao-Qing Wang; Lai Wang; Jin-Bo Deng
Journal:  Neural Regen Res       Date:  2017-03       Impact factor: 5.135

8.  "TRPV1 is a component of the atrial natriuretic signaling complex, and using orally delivered antagonists, presents a valid therapeutic target in the longitudinal reversal and treatment of cardiac hypertrophy and heart failure".

Authors:  Jaime S Horton; Takuya Shiraishi; Naghum Alfulaij; Andrea L Small-Howard; Helen C Turner; Tatsuki Kurokawa; Yasuo Mori; Alexander J Stokes
Journal:  Channels (Austin)       Date:  2019-12       Impact factor: 2.581

Review 9.  Does Transient Receptor Potential Vanilloid Type 1 Alleviate or Aggravate Pathological Myocardial Hypertrophy?

Authors:  Qiqi Yan; Jun Tang; Xin Zhang; Liuyang Wu; Yunyi Xu; Lihong Wang
Journal:  Front Pharmacol       Date:  2021-05-10       Impact factor: 5.810

10.  Transient Receptor Potential Vanilloid 4 Inhibits γ-Aminobutyric Acid-Activated Current in Hippocampal Pyramidal Neurons.

Authors:  Zhiwen Hong; Yujing Tian; Mengwen Qi; Yingchun Li; Yimei Du; Lei Chen; Wentao Liu; Ling Chen
Journal:  Front Mol Neurosci       Date:  2016-08-26       Impact factor: 5.639

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.